PTC Therapeutics, Inc. Accrued Income Taxes, Current
PTC Therapeutics, Inc. (PTCT) had Accrued Income Taxes, Current of $4.68 million as of 2025-12-31, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-07-30
- 2025-12-31: Accrued Income Taxes, Current $4.68M.
- 2025-09-30: Accrued Income Taxes, Current $2.93M.
- 2025-06-30: Accrued Income Taxes, Current $39.92M.
- 2025-03-31: Accrued Income Taxes, Current $64.62M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2025-12-31 | $4.68M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $2.93M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $39.92M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $64.62M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $4.70M 10-K · filed 2026-02-19 |
| 2024-09-30 | $6.01M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.70M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.83M 10-Q · filed 2024-04-25 |
| 2023-09-30 | $2.82M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $11.15M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $5.73M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $4.71M 10-K · filed 2024-02-29 |
| 2022-06-30 | $7.58M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.55M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $1.29M 10-K · filed 2023-02-21 |
| 2021-06-30 | $618.00K 10-Q · filed 2021-07-29 |
| 2021-03-31 | $3.91M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $4.32M 10-K · filed 2022-02-22 |
| 2020-09-30 | $21.48M 10-Q · filed 2020-10-29 |
| 2019-12-31 | $499.00K 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |